Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema.

[1]  William H. Yang,et al.  Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema. , 2004, The Journal of allergy and clinical immunology.

[2]  A. Tordai,et al.  Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond , 2004, Journal of Allergy and Clinical Immunology.

[3]  H. Farkas,et al.  The Hungarian HAE experience. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[4]  A. Tordai,et al.  Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema , 2003, Human mutation.

[5]  P. Kovanen,et al.  Role of complement activation in atherosclerosis , 2003, Current opinion in lipidology.

[6]  H. Farkas,et al.  Clinical management of hereditary angio‐oedema in children , 2002, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[7]  K. Bork,et al.  Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema. , 2002, Journal of hepatology.

[8]  M. Cicardi,et al.  C1-inhibitor deficiency and angioedema. , 2001, Molecular immunology.

[9]  Z. Prohászka,et al.  The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA)(n) polymorphism with coronary heart disease. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[10]  A. Porsius,et al.  Drug-Induced Lipid Changes , 2001, Drug safety.

[11]  H. Farkas,et al.  The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures. , 1999, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[12]  K. Bork,et al.  Hepatocellular adenomas in patients taking danazol for here ditary angiooedema , 1999, The Lancet.

[13]  D. Edmonds,et al.  Elevated Serum Lipoprotein(a) Levels in Young Women With Endometriosis , 1997 .

[14]  M. Cicardi,et al.  Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. , 1997, The Journal of allergy and clinical immunology.

[15]  J. Shepherd.  Danazol and plasma lipoprotein metabolism , 1995, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[16]  N. Hoogerbrugge,et al.  Danazol in the treatment of endometriosis and hereditary angio-oedema. , 1995, Journal of internal medicine.

[17]  H. Robenek,et al.  Kringle 4 of human apolipoprotein[a] shares a linear antigenic site with human catalase. , 1995, Journal of lipid research.

[18]  I. Cooke,et al.  Changes in Haematological Indices, Blood Viscosity and Inhibitors of Coagulation during Treatment of Endometriosis with Danazol , 1994, Thrombosis and Haemostasis.

[19]  G. Dahlén.  Lp(a) lipoprotein in cardiovascular disease. , 1994, Atherosclerosis.

[20]  C. Packard,et al.  Action of danazol on plasma lipids and lipoprotein metabolism. , 1994, Acta obstetricia et gynecologica Scandinavica. Supplement.

[21]  M. Seed,et al.  Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid. , 1992, Atherosclerosis.

[22]  R. Lawn,et al.  Lipoprotein(a) and atherosclerosis. , 1991, Annals of internal medicine.

[23]  E. Hack,et al.  Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience. , 1991, The Journal of allergy and clinical immunology.

[24]  M. Frank,et al.  The long-term safety of danazol in women with hereditary angioedema. , 1990, Fertility and sterility.

[25]  G. Andriole,et al.  Danazol-induced cystitis: an undescribed source of hematuria in patients with hereditary angioneurotic edema. , 1986, The Journal of urology.

[26]  G. Viale,et al.  Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives. , 1983, The Journal of allergy and clinical immunology.

[27]  R. Wallace,et al.  Effect of danazol on plasma lipid and lipoprotein levels in normal women. , 1982, Atherosclerosis.

[28]  E. Brown,et al.  Long-term therapy of hereditary angioedema with danazol. , 1980, Annals of internal medicine.

[29]  D. Alling,et al.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.

[30]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[31]  W. Osler.  HEREDITARY ANGIO‐NEUROTIC ŒDEMA , 1888 .